(Q73347727)

English

Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer

scientific article published on 01 March 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

R Haas

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

H Schmid

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

U Hahn

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

H Goldschmidt

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Murea

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Kaufmann

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Wannenmacher

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

D Wallwiener

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G Bastert

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

W Hunstein

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 March 1997

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

33

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

372-378

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2989008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2989008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of multidrug resistance in cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2989008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2989008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multi

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2989008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2989008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tandem autotransplantation for the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2989008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2989008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2989008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Epirubicin and ifosfamide in patients with refractory breast cancer and other metastatic solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2989008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2989008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive renal failure in two breast cancer patients after high-dose ifosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2989008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2989008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(97)89008-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9155519%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73347727&oldid=1753446409"